These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27810995)

  • 1. A Mobile Computerized Decision Support System to Prevent Hypoglycemia in Hospitalized Patients With Type 2 Diabetes Mellitus.
    Spat S; Donsa K; Beck P; Höll B; Mader JK; Schaupp L; Augustin T; Chiarugi F; Lichtenegger KM; Plank J; Pieber TR
    J Diabetes Sci Technol; 2017 Jan; 11(1):20-28. PubMed ID: 27810995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of errors in paper-based and computerized diabetes management with decision support for hospitalized patients with type 2 diabetes. A post-hoc analysis of a before and after study.
    Donsa K; Beck P; Höll B; Mader JK; Schaupp L; Plank J; Neubauer KM; Baumgartner C; Pieber TR
    Int J Med Inform; 2016 Jun; 90():58-67. PubMed ID: 27103198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardized Glycemic Management with a Computerized Workflow and Decision Support System for Hospitalized Patients with Type 2 Diabetes on Different Wards.
    Neubauer KM; Mader JK; Höll B; Aberer F; Donsa K; Augustin T; Schaupp L; Spat S; Beck P; Fruhwald FM; Schnedl C; Rosenkranz AR; Lumenta DB; Kamolz LP; Plank J; Pieber TR
    Diabetes Technol Ther; 2015 Oct; 17(10):685-92. PubMed ID: 26355756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GlucoTab-guided insulin therapy using insulin glargine U300 enables glycaemic control with low risk of hypoglycaemia in hospitalized patients with type 2 diabetes.
    Aberer F; Lichtenegger KM; Smajic E; Donsa K; Malle O; Samonigg J; Höll B; Beck P; Pieber TR; Plank J; Mader JK
    Diabetes Obes Metab; 2019 Mar; 21(3):584-591. PubMed ID: 30328252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safe and Sufficient Glycemic Control by Using a Digital Clinical Decision Support System for Patients With Type 2 Diabetes in a Routine Setting on General Hospital Wards.
    Lichtenegger KM; Aberer F; Tuca AC; Donsa K; Höll B; Schaupp L; Plank J; Beck P; Fruhwald FM; Kamolz LP; Pieber TR; Mader JK
    J Diabetes Sci Technol; 2021 Mar; 15(2):231-235. PubMed ID: 32914640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting.
    Aloi J; Bode BW; Ullal J; Chidester P; McFarland RS; Bedingfield AE; Mabrey M; Booth R; Mumpower A; Wallia A
    J Diabetes Sci Technol; 2017 Jan; 11(1):12-16. PubMed ID: 27555601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of Inpatient CGM: Comparison to Standard of Care.
    Price C; Ditton G; Russell GB; Aloi J
    J Diabetes Sci Technol; 2023 Mar; 17(2):329-335. PubMed ID: 34911384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, usability and sequence of operations of a workflow-integrated algorithm for basal-bolus insulin therapy in hospitalized type 2 diabetes patients.
    Mader JK; Neubauer KM; Schaupp L; Augustin T; Beck P; Spat S; Höll B; Treiber GM; Fruhwald FM; Pieber TR; Plank J
    Diabetes Obes Metab; 2014 Feb; 16(2):137-46. PubMed ID: 23910952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing Hypoglycemia in the Real World: A Retrospective Analysis of Predictive Low-Glucose Suspend Technology in an Ambulatory Insulin-Dependent Cohort.
    Müller L; Habif S; Leas S; Aronoff-Spencer E
    Diabetes Technol Ther; 2019 Sep; 21(9):478-484. PubMed ID: 31329468
    [No Abstract]   [Full Text] [Related]  

  • 10. Dosing irregularities and self-treated hypoglycemia in type 2 diabetes: results from the Canadian cohort of an international survey of patients and healthcare professionals.
    Leiter LA; Boras D; Woo VC
    Can J Diabetes; 2014 Feb; 38(1):38-44. PubMed ID: 24485212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving IV insulin administration in a community hospital.
    Magee MC
    J Vis Exp; 2012 Jun; (64):e3705. PubMed ID: 22710978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes patients' experiences with the implementation of insulin therapy and their perceptions of computer-assisted self-management systems for insulin therapy.
    Simon AC; Gude WT; Holleman F; Hoekstra JB; Peek N
    J Med Internet Res; 2014 Oct; 16(10):e235. PubMed ID: 25340869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taking a Closer Look--Continuous Glucose Monitoring in Non-Critically Ill Hospitalized Patients with Type 2 Diabetes Mellitus Under Basal-Bolus Insulin Therapy.
    Schaupp L; Donsa K; Neubauer KM; Mader JK; Aberer F; Höll B; Spat S; Augustin T; Beck P; Pieber TR; Plank J
    Diabetes Technol Ther; 2015 Sep; 17(9):611-8. PubMed ID: 25927357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and tolerability of treatment intensification to basal-bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study.
    Pfohl M; Siegmund T; Pscherer S; Pegelow K; Seufert J
    Vasc Health Risk Manag; 2015; 11():569-78. PubMed ID: 26604774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased rates of hypoglycemia following implementation of a comprehensive computerized insulin order set and titration algorithm in the inpatient setting.
    Sinha Gregory N; Seley JJ; Gerber LM; Tang C; Brillon D
    Hosp Pract (1995); 2016 Dec; 44(5):260-265. PubMed ID: 27805455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Review Supporting the Endocrine Society Guidelines: Management of Diabetes and High Risk of Hypoglycemia.
    Torres Roldan VD; Urtecho M; Nayfeh T; Firwana M; Muthusamy K; Hasan B; Abd-Rabu R; Maraboto A; Qoubaitary A; Prokop L; Lieb DC; McCall AL; Wang Z; Murad MH
    J Clin Endocrinol Metab; 2023 Feb; 108(3):592-603. PubMed ID: 36477885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized Controlled Trial on the Safety and Efficacy of Exenatide Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes.
    Fayfman M; Galindo RJ; Rubin DJ; Mize DL; Anzola I; Urrutia MA; Ramos C; Pasquel FJ; Haw JS; Vellanki P; Wang H; Albury BS; Weaver R; Cardona S; Umpierrez GE
    Diabetes Care; 2019 Mar; 42(3):450-456. PubMed ID: 30679302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a Basal-Bolus Insulin Regimen on Metabolic Control and Risk of Hypoglycemia in Patients With Diabetes Undergoing Peritoneal Dialysis.
    Gómez AM; Vallejo S; Ardila F; Muñoz OM; Ruiz ÁJ; Sanabria M; Bunch A; Morros E; Kattah L; García-Jaramillo M; León-Vargas F
    J Diabetes Sci Technol; 2018 Jan; 12(1):129-135. PubMed ID: 28927285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter, open-label, nonrandomized, observational safety study in subjects using insulin aspart in basal-bolus regimen for the treatment of diabetes.
    Krzymień J; Kobli T; Nazar M
    Pol Arch Med Wewn; 2010 Nov; 120(11):444-50. PubMed ID: 21102380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into optimal basal insulin titration in type 2 diabetes: Results of a quantitative survey.
    Berard L; Bonnemaire M; Mical M; Edelman S
    Diabetes Obes Metab; 2018 Feb; 20(2):301-308. PubMed ID: 28719066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.